Indefinite Delivery Contract 36E79726D0009
- Not listed
- Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer specializing in vaccine production, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs' National Acquisition Center (acting as the Civilian Funding Agency) on March 15, 2025, with a ceiling value of $113,670.50 and a performance period extending through March 14, 2026. This contract procures Influenza Virus Vaccine for the 2025-2026 flu season and incorporates a 2026 Small Business...
- The federal contract IDV award is for the procurement of influenza virus vaccines for the 2024-2025 flu season. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. This award is being made by the U.S. Department of Veterans Affairs (VA) National Acquisition Center and will be used to supply vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. The...
- The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Sanofi Pasteur Inc. for the supply of influenza vaccines. Task orders issued by VA, Federal Bureau of Prisons, Indian Health Service, and Department of Health and Human Services procure influenza virus vaccines in pre-filled syringes and multi-dose vials for individuals over 18 years old. Additional line items provide syringes tailored for those 65 and older as well as children ages 36...
- Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer specializing in vaccine production, holds a multiple-award Federal Supply Schedule contract under the General Services Administration for Pharmaceuticals and Drugs (FSS-61-IB) with a ceiling value of $634 million and an ultimate completion date of April 14, 2027. The contract was awarded on April 15, 2022, without set-aside designation to the Veterans Integrated Service Network 12, a civilian agency within the Department of...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
- The Defense Logistics Agency Troop Support Medical awarded Sanofi Pasteur Inc. an indefinite delivery contract with a potential value of $8,519,232.30 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to date for a total of $5,729,208.20. The delivery orders require Sanofi Pasteur to provide vaccinations from its Swiftwater, Pennsylvania facility to the agency between March 2023 and October 2023. The originating...
- This single-award Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult influenza vaccines for the 2022-2023 flu season. The contract has a ceiling value of $65,825,903.80 and a period of performance from the date of award on December 31, 2021 through February 28, 2023. The original solicitation sought proposals for IDIQ contracts to supply a minimum of 100 doses and a maximum of 20 million doses of...
- The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Seqirus USA Inc. to deliver influenza virus vaccines for the 2022-2023 season to the VA, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. Task orders under the contract, with a potential value of $69,190,924.13, provide vaccines including 10-dose vials, single dose syringes in boxes of 10, and an adjuvant vaccine for individuals aged 65 and...
- Sanofi Pasteur Inc. was awarded an Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) on December 31, 2025, with a ceiling value of $18.07 million and an ultimate completion date of February 28, 2027. The contract is structured as a multiple-award Indefinite Delivery/Indefinite Quantity agreement without set-aside designation, established to procure adult flu vaccines for federal immunization programs. The awardee, a foreign-owned pharmaceutical manufacturer...
- Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain (a component of the Department of Defense) with a ceiling value of approximately $25.1 million and an ultimate completion date of February 13, 2026. The contract, awarded on February 14, 2025, is for the supply of influenza virus vaccines to support federal immunization...
This single-award Indefinite Delivery Contract, issued by the Department of Veterans Affairs National Acquisition Center on March 15, 2026, procures Influenza Virus Vaccine for the 2026-2027 influenza season from Sanofi Pasteur Inc., a pharmaceutical manufacturer specializing in vaccine production. The contract carries a ceiling value of $8.67 million and extends through March 14, 2027. The procurement serves multiple federal agencies including the Department of Veterans Affairs, State Veteran Homes, Federal Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. This commercial item procurement was conducted under Federal Acquisition Regulation Part 12, with evaluation and award based on individual solicitation line items by agency, requiring contractors to offer full quantities for selected line items at uniform pricing that includes cost recovery fees and Federal Excise Tax. Delivery is specified on a Free On Board Destination basis to government facilities throughout the United States, Philippines, and Puerto Rico, with mandatory delivery schedules requiring at least 50 percent of each facility's order between August 15 and September 15, 2026, and the remaining quantity by October 15, 2026. The contract represents a critical procurement component of federal immunization programs and public health preparedness. Sanofi Pasteur Inc., registered in SAM.gov since 2002 and headquartered in Swiftwater, Pennsylvania, maintains an extensive portfolio of federal vaccine contracts and holds multiple high-value Indefinite Delivery Contracts with federal agencies, including influenza vaccine contracts ranging from $15 million to $47.5 million. The underlying solicitation, RFP 36E79725R0064, was issued without set-aside designations, making it available to all qualified contractors. This procurement falls under North American Industry Classification System code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505 (Drugs and Biologicals), reflecting the specialized nature of vaccine manufacturing and distribution for federal populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 12/15/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Influenza Virus Vaccine 2026-2027 Flu Season Line Items 1, 3, 5, 7, and 8 | 36E79725R0064 | Department of Veterans Affairs National Acquisition Center | Award Notice 3/4 | 12/15/25, 10:42 AM | |
6505--2026-2027 Influenza Virus Vaccine | 36E79725R0064 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/4 | 9/29/25, 11:14 AM | |
6505--Influenza Virus Vaccine 2026-2027 Flu Season Line Items 2, 4, 6, and 9 | 36E79725R0064 | Department of Veterans Affairs National Acquisition Center | Award Notice 4/4 | 12/15/25, 10:53 AM | |
6505--2026-2027 Influenza Virus Vaccine | 36E79725R0064 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/4 | 10/9/25, 8:21 AM |